Certain human GST isoforms have been shown to exert their protective effects through this ligandin-like behavior by binding with high affinity to inhibitory prostaglandins (e.g., PGJ2), effectively sequestering them in the cytosol away from target nuclear proteins and preventing effects on gene regulation [39], [43].
The p65 and p50 NF- κB heterodimers are maintained inactive in the cytosol by the binding with an inhibitory protein, namely, inhibitor of NF- κB (I κB) [ 48].
Cell surface-expressed trophoblast HLA-G can suppress immune responses by binding to inhibitory receptors.
In a related scenario, Ca2+ downregulates the deAMPylation activity of FICD by binding in an inhibitory manner where it competes with Mg2+.
Under basal conditions, NF- κB is inactive by associated with inhibitory proteins in the cytoplasm to prevent DNA binding for transcription activity.
Under normal physiological conditions, the inflammatory response is terminated by binding NF-κB with the inhibitory protein IκB [ 56, 57].
Specificity of antibody binding was determined by using commercially available recombinant p38α, p38β, p38γ and p38δ proteins (Upstate/Millipore, Billerica, MA, USA) and by competition with inhibitory peptides (results not shown).
The SH3 domain might do so by either interaction with inhibitory proteins or an intramolecular inhibitory mechanism.
In inducing conditions, cAMP is generated by adenylate cyclase (Cyr1) and triggers PKA activity by binding and removal of the inhibitory subunit Bcy1, which associates with Tpk1 and Tpk2 [ 5– 7].
cAMP regulates PKA activity by binding to Bcy1, alleviating its inhibitory activity on the catalytic subunits.
